Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ralph Weissleder, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ralph Weissleder and Jack Wittenberg.
Connection Strength

0.636
  1. AUR Memorial Award 1993. A drug system (PDH) for interventional radiology. Synthesis, properties, and efficacy. Invest Radiol. 1993 Dec; 28(12):1083-9.
    View in: PubMed
    Score: 0.145
  2. Polymeric contrast agents for MR imaging of adrenal glands. J Magn Reson Imaging. 1993 Jan-Feb; 3(1):93-7.
    View in: PubMed
    Score: 0.136
  3. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology. 1991 May; 179(2):529-33.
    View in: PubMed
    Score: 0.030
  4. Lymph nodes: microstructural anatomy at MR imaging. Radiology. 1991 Feb; 178(2):519-22.
    View in: PubMed
    Score: 0.030
  5. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. AJR Am J Roentgenol. 1990 Dec; 155(6):1161-7.
    View in: PubMed
    Score: 0.029
  6. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology. 1990 May; 175(2):489-93.
    View in: PubMed
    Score: 0.028
  7. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology. 1990 May; 175(2):494-8.
    View in: PubMed
    Score: 0.028
  8. MRI of hepatic lymphoma. Magn Reson Imaging. 1988 Nov-Dec; 6(6):675-81.
    View in: PubMed
    Score: 0.025
  9. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology. 1988 Nov; 169(2):399-403.
    View in: PubMed
    Score: 0.025
  10. Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. AJR Am J Roentgenol. 1988 Jul; 151(1):79-84.
    View in: PubMed
    Score: 0.025
  11. Dual-contrast MR imaging of liver cancer in rats. AJR Am J Roentgenol. 1988 Mar; 150(3):561-6.
    View in: PubMed
    Score: 0.024
  12. Pyogenic liver abscess: contrast-enhanced MR imaging in rats. AJR Am J Roentgenol. 1988 Jan; 150(1):115-20.
    View in: PubMed
    Score: 0.024
  13. Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats. AJR Am J Roentgenol. 1987 Dec; 149(6):1161-5.
    View in: PubMed
    Score: 0.024
  14. Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays. Radiology. 1992 Feb; 182(2):565-9.
    View in: PubMed
    Score: 0.008
  15. Asialoglycoprotein receptor function in benign liver disease: evaluation with MR imaging. Radiology. 1991 Mar; 178(3):769-74.
    View in: PubMed
    Score: 0.007
  16. Receptor imaging: application to MR imaging of liver cancer. Radiology. 1990 Dec; 177(3):729-34.
    View in: PubMed
    Score: 0.007
  17. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgenol. 1990 Oct; 155(4):763-70.
    View in: PubMed
    Score: 0.007
  18. The differential diagnosis of ringed hepatic lesions in MR imaging. AJR Am J Roentgenol. 1990 Feb; 154(2):287-90.
    View in: PubMed
    Score: 0.007
  19. Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology. 1989 May; 171(2):323-6.
    View in: PubMed
    Score: 0.007
  20. MR imaging of liver neoplasms. AJR Am J Roentgenol. 1989 Mar; 152(3):493-9.
    View in: PubMed
    Score: 0.007
  21. Primary liver tumors: diagnosis by MR imaging. AJR Am J Roentgenol. 1989 Jan; 152(1):63-72.
    View in: PubMed
    Score: 0.006
  22. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology. 1988 Aug; 168(2):297-301.
    View in: PubMed
    Score: 0.006
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.